{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.52","value":"126.5"},{"groupId":"OG001","spread":"12.00","value":"126.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"434"},{"groupId":"OG001","value":"439"}],"units":"Participants"}],"title":"Baseline: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.08","value":"4.7"},{"groupId":"OG001","spread":"12.49","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"380"},{"groupId":"OG001","value":"344"}],"units":"Participants"}],"title":"Change at Cycle 2, Day 1: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.43","value":"3.8"},{"groupId":"OG001","spread":"12.81","value":"1.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"363"},{"groupId":"OG001","value":"310"}],"units":"Participants"}],"title":"Change at Cycle 3, Day 1: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.95","value":"3.0"},{"groupId":"OG001","spread":"13.01","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"342"},{"groupId":"OG001","value":"271"}],"units":"Participants"}],"title":"Change at Cycle 4, Day 1: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.42","value":"2.5"},{"groupId":"OG001","spread":"12.26","value":"-0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"332"},{"groupId":"OG001","value":"244"}],"units":"Participants"}],"title":"Change at Cycle 5, Day 1: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.39","value":"1.6"},{"groupId":"OG001","spread":"12.97","value":"-0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"310"},{"groupId":"OG001","value":"215"}],"units":"Participants"}],"title":"Change at Cycle 6, Day 1: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.39","value":"1.9"},{"groupId":"OG001","spread":"13.56","value":"0.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"282"},{"groupId":"OG001","value":"191"}],"units":"Participants"}],"title":"Change at Cycle 7, Day 1: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.40","value":"0.9"},{"groupId":"OG001","spread":"15.67","value":"1.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"205"},{"groupId":"OG001","value":"273"}],"units":"Participants"}],"title":"Change at End of Treatment: Sitting SBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.32","value":"75.7"},{"groupId":"OG001","spread":"9.41","value":"75.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"434"},{"groupId":"OG001","value":"439"}],"units":"Participants"}],"title":"Baseline: Sitting DBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.92","value":"5.8"},{"groupId":"OG001","spread":"8.60","value":"-0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"380"},{"groupId":"OG001","value":"344"}],"units":"Participants"}],"title":"Change at Cycle 2, Day 1: Sitting DBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.98","value":"4.9"},{"groupId":"OG001","spread":"9.64","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"363"},{"groupId":"OG001","value":"310"}],"units":"Participants"}],"title":"Change at Cycle 3, Day 1: Sitting DBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.61","value":"4.8"},{"groupId":"OG001","spread":"9.30","value":"-1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"342"},{"groupId":"OG001","value":"271"}],"units":"Participants"}],"title":"Change at Cycle 4, Day 1: Sitting DBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.17","value":"4.5"},{"groupId":"OG001","spread":"9.71","value":"-1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"332"},{"groupId":"OG001","value":"244"}],"units":"Participants"}],"title":"Change at Cycle 5, Day 1: Sitting DBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.18","value":"3.8"},{"groupId":"OG001","spread":"9.89","value":"-1.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"310"},{"groupId":"OG001","value":"215"}],"units":"Participants"}],"title":"Change at Cycle 6, Day 1: Sitting DBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.04","value":"3.8"},{"groupId":"OG001","spread":"9.90","value":"-1.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"282"},{"groupId":"OG001","value":"191"}],"units":"Participants"}],"title":"Change at Cycle 7, Day 1: Sitting DBP"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.70","value":"1.5"},{"groupId":"OG001","spread":"10.92","value":"-0.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"205"},{"groupId":"OG001","value":"273"}],"units":"Participants"}],"title":"Change at End of Treatment: Sitting DBP"}],"denoms":[{"counts":[{"groupId":"OG000","value":"434"},{"groupId":"OG001","value":"439"}],"units":"Participants"}],"description":"Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured with the participant in the seated position after the participant had been sitting quietly for at least 5 minutes.","dispersionType":"Standard Deviation","groups":[{"description":"Participants with aRCC received avelumab 10 mg/kg, IV at Q2W in a 6-week cycle plus axitinib 5 mg, orally BID. Each treatment cycle was 42 days.","id":"OG000","title":"Avelumab + Axitinib"},{"description":"Participants with aRCC received sunitinib 50 mg orally, QD on a schedule of 4 weeks on treatment followed by 2 weeks off treatment (schedule 4/2 in 6-week cycles). Each treatment cycle was of 42 days.","id":"OG001","title":"Sunitinib"}],"paramType":"MEAN","populationDescription":"Safety analysis set included all participants who received at least one dose of study drug. \"Number Analyzed\" signifies number of participants evaluable for the specified time points.","reportingStatus":"POSTED","timeFrame":"Baseline (pre-dose on Day 1 of Cycle 1), Day 1 of Cycle 2, 3, 4, 5, 6, 7, EOT visit (maximum up to approximately 89 months) (each cycle=42 days)","title":"Change From Baseline in Vital Signs - Blood Pressure at Day 1 of Cycle 2, 3, 4, 5, 6, 7 and End of Treatment (EOT) Visit","type":"SECONDARY","unitOfMeasure":"Millimeters of mercury"}